Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients.

Khurram BariKeith LuckettTiffany KaiserTayyab DiwanMadison CuffyMichael R SchoechKamran SafdarJason T BlackardSenu ApewokinFlavio PaternoKenneth E ShermanStephen D ZuckerNadeem AnwarShimul A Shah

Published in: Hepatology (Baltimore, Md.) (2018)

In this prospective cohort of non-HCV liver recipients receiving grafts from HCV antibody-positive/NAT-negative donors, the incidence of HCV transmission was 16%, with the highest risk conferred by donors who died of drug overdose; given the availability of safe and highly effective antiviral therapies, use of such organs could be considered to expand the donor pool. (Hepatology 2018;67:1673-1682).

Keyphrases

hepatitis c virus
kidney transplantation
human immunodeficiency virus
risk factors
emergency department
hiv infected
drug induced
electronic health record